Senior Director of Drug Product Development
Arvinas
Summary
The Senior Director leads early drug product formulation, process development, and outsourced clinical manufacture, with emphasis on first-in-human and Phase 2 programs. The role combines formulation and pre-formulation experience with required spray drying, tableting, and parenteral expertise, experience with PEG-containing candidates, and working knowledge of biologics formulation. The incumbent directs external partners, mentors staff, and owns functional delivery and budgets. Demonstrated success advancing multiple programs through IND-enabling development and Phase 1/2 is essential.
Job description
Position Summary
The Senior Director leads early drug product formulation, process development, and outsourced clinical manufacture, with emphasis on first-in-human and Phase 2 programs. The role combines formulation and pre-formulation experience with required spray drying, tableting, and parenteral expertise, experience with PEG-containing candidates, and working knowledge of biologics formulation. The incumbent directs external partners, mentors staff, and owns functional delivery and budgets. Demonstrated success advancing multiple programs through IND-enabling development and Phase 1/2 is essential.
Principal Responsibilities
- Lead drug product strategy and execution for IND-enabling support, first-in-human studies, and Phase 2, defining formulation options, decision criteria, timelines, budgets, and mitigation plans.
- Apply pre-formulation experience to interpret solubility, solid-state, dissolution, stability, and excipient compatibility data.
- Partner with Pre-formulation to translate findings into practical formulations and resolve knowledge gaps.
- Direct spray drying and amorphous solid dispersion development, including polymer and solvent selection, drug loading, residual solvent control, physical stability, scale-up, and technology transfer.
- Lead tablet formulation and process development, including blending, compression or granulation, and coating as appropriate; address manufacturability, content uniformity, and dissolution.
- Lead parenteral formulation development, including solutions and/or lyophilized products, excipient and container selection, stability, dilution, and administration compatibility.
- Assess formulation implications of PEG derivatives and PEG-containing candidates.
- Apply working knowledge of biologics formulation, including aggregation, adsorption, protein stability, freeze-thaw sensitivity, and excipient selection; engage specialists as needed.
- Select and manage CDMOs for formulation, oral solid dosage manufacture, and sterile products. Own technical scopes, transfers, manufacturing readiness, vendor performance, and delivery against approved plans.
- Partner with Analytical Development and Quality Assurance on specifications, release testing, stability, shelf life, and in-use requirements.
- Ensure appropriate sterility assurance, contamination controls, and container-closure integrity with qualified sterile manufacturers.
- Lead drug product content for INDs and clinical amendments; coordinate clinical manufacture and handover to Clinical Supply.
- Manage budgets and staff, resolve investigations and changes with Quality Assurance, and communicate technical options and supply risks.
Qualifications
- Repeated success developing and delivering formulations for multiple IND-enabling and Phase 1/2 programs, adapting presentations and processes as dose, material availability, and clinical needs evolve.
- Experience in early formulation and pre-formulation, with the ability to interpret compound characterization and apply it to product development.
- Spray drying and tableting experience is required, including amorphous solid dispersions, formulation and process optimization, and transfer to clinical manufacturing partners.
- Parenteral formulation experience is required, including injectable development and technical oversight of sterile manufacturing vendors.
- Experience with PEG derivatives or PEG-containing drug candidates, plus working knowledge of biologics formulation, including stability, aggregation, adsorption, and excipient selection.
- Strong CDMO management, clinical CMC submission, and phase-appropriate cGMP experience; demonstrated creativity, calculated risk assessment, team leadership, budget ownership, and cross-functional delivery.
- Provide senior functional leadership while remaining closely involved in technical reviews, vendor decisions, and problem-solving.
- Develop internal talent and collaborate effectively across Drug Substance, Drug Product, Analytical Development, Clinical Supply, Quality Assurance, CMC Regulatory Affairs, and project teams.
Education
Ph.D. in Pharmaceutics, Pharmaceutical Sciences, Chemistry, Chemical Engineering, or a related discipline with typically 15 or more years of relevant pharmaceutical or biotechnology experience, or a BS/M.S. with typically 20 or more years. Experience must include substantial drug product leadership and repeated early clinical delivery; equivalent combinations of education and relevant experience may be considered.
Requirements
- Repeated success developing and delivering formulations for multiple IND-enabling and Phase 1/2 programs
- Experience in early formulation and pre-formulation
- Spray drying and tableting experience required, including amorphous solid dispersions
- Parenteral formulation experience required, including injectable development and sterile manufacturing vendor oversight
- Experience with PEG derivatives or PEG-containing drug candidates
- Working knowledge of biologics formulation including stability, aggregation, adsorption, and excipient selection
- Strong CDMO management experience
- Clinical CMC submission experience
- Phase-appropriate cGMP experience
- Demonstrated team leadership and budget ownership
- Cross-functional collaboration skills
- Ph.D. in Pharmaceutics, Pharmaceutical Sciences, Chemistry, Chemical Engineering, or related discipline with typically 15+ years experience, or BS/MS with typically 20+ years
- Ability to work without need for current or future VISA sponsorship
Benefits
- Group Medical Coverage
- Vision Coverage
- Dental Coverage
- Group Life Insurance
- Supplemental Life Insurance
- Incentive Compensation
Company overview
Arvinas is a clinical-stage biotechnology company pioneering the development of targeted protein degradation therapeutics through its revolutionary PROTAC (PROteolysis TArgeting Chimeras) platform. Founded in 2013 and headquartered in New Haven, Connecticut, the company focuses on creating novel therapies that harness the body's natural protein disposal system to selectively degrade and remove disease-causing proteins. Arvinas is advancing multiple investigational drugs through clinical development programs, including vepdegestrant for ER+/HER2- breast cancer, ARV-393 for non-Hodgkin Lymphoma, and ARV-102 for neurodegenerative disorders. The company's PROTAC Discovery Engine represents a breakthrough approach that can target proteins previously considered 'undruggable' by traditional methods, offering potential advantages in oncology and neurology. With a team of 201-500 employees, Arvinas collaborates with leading pharmaceutical partners and academic institutions to accelerate its clinical programs and bring transformative treatments to patients with serious diseases.